Document:

Exhibit

Exhibit 10.1
WAIVER
This Waiver (this "Waiver"), dated as of April 1, 2017, is made by and JGB (Cayman) Newton Ltd. (the "Holder") in favor of Galena Biopharma, Inc., a Delaware corporation (the "Company").  
WHEREAS, the Holder and the Company have entered into a Securities Purchase Agreement dated as of May 10, 2016 (as the same may be amended, amended and restated, supplemented or otherwise modified from time to time in accordance with its provisions, the "Securities Purchase Agreement"), whereby the Company issued and sold to the Holder, and the Holder purchased from the Company, a 9% Original Issue Discount Senior Secured Convertible Debenture in the original principal amount of $25,350,000 (as amended and restated on August 22, 2016, and as subsequently amended on December 14, 2016, the “Debenture”);
WHEREAS, the Company’s obligations under the Debenture and the other Transaction Documents (as defined in the Securities Purchase Agreement) are unconditionally guaranteed by each of the entities executing this Waiver as a guarantor (collectively, the “Guarantors” and each a “Guarantor”) pursuant to a subsidiary guaranty dated May 10, 2016 (the “Subsidiary Guaranty”);
WHEREAS, as security for all of the indebtedness and obligations due to Holders under the Debenture and the other Transaction Documents (collectively, the "Obligations"), Company and the Guarantors executed and delivered to JGB Collateral, LLC, as security agent for the Holder (the “Agent”), a Security Agreement dated as of May 10, 2016 (as the same may be amended, amended and restated, supplemented or otherwise modified from time to time in accordance with its provisions, the "Security Agreement"), granting to the Agent on behalf of Holder a security interest in the collateral, as defined in the Security Agreement (the "Collateral"); and
WHEREAS, an Equity Conditions Failure (as defined in the Debenture) has occurred and is continuing as a result of the VWAP (as defined in the Debenture) for the Common Stock not being at least $4.00 per share (the “Specified ECF”) and the Company and the Guarantors have requested that the Holder waive the Specified ECF subject to the terms and conditions contained herein.
NOW, THEREFORE, in consideration of the premises set forth above and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
Definitions. Capitalized terms used and not defined in this Waiver shall have the respective meanings given them in the Debenture.
Company and Guarantor Acknowledgments. The Company and the Guarantors acknowledge and agree that: 

Transaction Documents. The Debenture, the Securities Purchase Agreement, the Subsidiary Guaranty, the Security Agreement, the December 14 Waiver (as defined below), this Waiver, the other Transaction Documents and all other agreements, instruments and other documents executed in connection with or relating thereto (collectively, the "Debenture Documents") are legal, valid, binding and enforceable against the Company and Guarantors in accordance with their terms. 
Obligations. The respective obligations of the Company and the Guarantors under the Debenture Documents are not subject to any setoff, deduction, claim, counterclaim or defenses of any kind or character whatsoever.
Collateral. The Agent (on behalf of the Holder) has valid, enforceable and perfected first priority security interests in and liens on the Collateral (as defined in the Security Agreement), as to which there are no setoffs, deductions, claims, counterclaims or defenses of any kind or character whatsoever.  Nothing contained herein shall impair or limit the continuation of the Agent’s liens and security interests in the Collateral or the continued perfection or priority thereof.  
Holder Conduct. The Holder and the Agent have fully and timely performed all of its obligations and duties in compliance with the Debenture Documents and applicable law, and has acted reasonably, in good faith and appropriately under the circumstances.
Waiver of Specified ECF.  Solely with respect to the calendar months of April 2017, May 2017, June 2017, July 2017, August 2017 and September 2017 (collectively, the “Specified Months”), Holder hereby waives the requirement of paragraph (i) of the definition of “Equity Conditions” set forth in Section 1 of the Debenture; provided, however, that, the foregoing waiver shall be subject to the following conditions: (a) with respect to each Specified Month, the VWAP of the Common Stock is not less than $0.30 per share (appropriately adjusted for any stock split, stock dividend, stock combination, stock buy-back or other similar transaction) on any Trading Day of such Specified Month (b) no Event of Default has occurred and is continuing and (c) the Company’s cash on hand exceeds the outstanding principal amount of the Debenture by at least $10,000,000 (clauses (a) - (c), the “Waiver Conditions”).  For the avoidance of doubt, in the event that any Waiver Condition fails to be satisfied during any Specified Month, the Debenture shall automatically be Stock Off for the remainder of such calendar month and the Holder shall be entitled to receive the entire Monthly Allowance for such Specified Month in cash (but may still request shares of Common Stock).  Notwithstanding the foregoing waiver, the Company may not exercise the Company Force Right so long as the Equity Conditions are not satisfied precisely as written in the Debenture without regard to this Waiver.  The Company acknowledges and notifies the Holder that the Debenture shall be Stock On for the Specified Months subject to the satisfaction of the Waiver Conditions.  
Limitation of Waiver. The waiver set forth above shall be limited precisely as written and relates solely to clause (i) of the definition of “Equity Conditions” set forth in Section 1 of the Debenture and solely with respect to the Specified Months in the manner and to the extent described above and nothing in this Waiver shall be deemed to constitute a waiver 

of compliance by the Company or any Guarantor with respect to any other term, provision or condition of the Debenture or any other Debenture Document, or any other instrument or agreement referred to therein; or prejudice any right or remedy that the Holder at any time under the Debenture may now have or may have in the future under or in connection with the Debenture or any other Debenture Document, or any other instrument or agreement referred to therein.
No Modification.  Nothing contained in this Waiver shall be deemed or construed to amend, supplement or modify the Debenture or any other Debenture Documents or otherwise affect the rights and obligations of any party thereto, all of which remain in full force and effect.  For the avoidance of doubt, nothing herein shall be deemed to supersede, amend, cancel or otherwise modify Sections 5 and 6 of the Waiver dated December 14, 2016 (the “December 14 Waiver”) and such section survives the execution hereof.   
Representations, Warranties and Covenants.  The Company and each Guarantor represents and warrants to the Holder that, as of the date hereof that (i) no Event of Default under the Debenture has occurred or is continuing, (2) the Company and each Guarantor has complied in all material respects with their respective obligations under the Debenture Documents, and (3) the Company’s execution and delivery of this Waiver does not conflict with, and will not result in a default or violation under, any other agreement or instrument to which the Company or any Guarantor is a party.
Successors and Assigns.  This Waiver shall inure to the benefit of and be binding upon the Company, each Guarantor and the Holder, and each of their respective successors and assigns. 
Governing Law. This Waiver shall be governed by, and construed in accordance with, the laws of the State of New York.  The parties agree that the state and federal courts located in New York County, New York shall have exclusive jurisdiction over any action, proceeding or dispute arising out of this Waiver and the parties submit to the personal jurisdiction of such courts.
Counterparts. This Waiver may be executed in any number of counterparts, all of which shall constitute one and the same agreement, and any party hereto may execute this Waiver by signing and delivering one or more counterparts. Delivery of an executed counterpart of this Waiver electronically or by facsimile shall be effective as delivery of an original executed counterpart of this Waiver.
Disclosure.  The Company confirms that neither it nor any other person or entity acting on its behalf has provided Holder or its counsel with any information that constitutes or might constitute material, nonpublic information.  The Company shall disclose the material terms of this waiver pursuant to Item 8.01 of Form 8-K by not later than 5 p.m. (local time in New York, New York) on the date hereof. 
[Signature Page Follows.]

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

Galena Biopharma, Inc.,
as Company
By:    /s/ Stephen Ghiglieri
Name:  Stephen Ghiglieri
Title:  Interim Chief Executive Officer

Apthera, Inc., as Guarantor 

By:    /s/ Stephen Ghiglieri
Name:  Stephen Ghiglieri
Title:  Interim Chief Executive Officer

Mills Pharmaceuticals, LLC, as Guarantor 

By:    /s/ Stephen Ghiglieri
Name:  Stephen Ghiglieri
Title: Interim Chief Executive Officer

JGB (Cayman) Newton Ltd., as Holder

By____/s/ Brett Cohen_
Name:  Brett Cohen
Title:  President & CEO

JGB Collateral LLC, as Agent
By____/s/ Brett Cohen_
Name:  Brett Cohen
Title:  PresidentINVESTMENT
AGREEMENT

 

INVESTMENT
AGREEMENT (this “AGREEMENT”), dated as of March 6, 2017 by and between PHI GROUP, INC., a Nevada corporation (the
“Company”), and Azure Capital, a Massachusetts corporation (the “Investor”).

 

WHEREAS,
the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to ten million
dollars ($10,000,000) to purchase the Company’s Common Stock with .001 par value per share (the “Common Stock”);

 

WHEREAS,
such investments will be made in reliance upon the provisions of Section 4(2) under the Securities Act of 1933, as amended (the
“1933 Act”), Rule 506 of Regulation D, and the rules and regulations promulgated thereunder, and/or upon such other
exemption from the registration requirements of the 1933 Act as May be available with respect to any or all of the investments
in Common Stock to be made hereunder; and

 

WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration
Rights Agreement substantially in the form attached hereto (the “Registration Rights Agreement”) pursuant to which
the Company has agreed to provide certain registration rights under the 1933 Act, and the rules and regulations promulgated thereunder,
and applicable state securities laws.

 

NOW
THEREFORE, in consideration of the foregoing recitals, which shall be considered an integral part of this Agreement, the covenants
and agreements set forth hereafter, and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Company and the Investor hereby agree as follows:

 

SECTION
1. DEFINITIONS.

 

As
used in this Agreement, the following terms shall have the following meanings specified or indicated below, and such meanings
shall be equally applicable to the singular and plural forms of such defined terms.

 

“1933
Act” shall have the meaning set forth in the recitals of this Agreement.

 

“1934
Act” shall mean the Securities Exchange Act of 1934, as it may be amended.

 

“AAA”
shall have the meaning specified in Section 11.

 

“Affiliate”
shall have the meaning specified in Section 5(H).

 

“Agreement”
shall mean this Investment Agreement.

 

“Articles
of Incorporation” shall have the meaning specified in Section 4(C).

 

“By-laws”
shall have the meaning specified in Section 4(C).

 

“Closing”
shall have the meaning specified in Section 2(E).

 

“Closing
Date” shall have the meaning specified in Section 2(E).

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	1 	 

    	 

    

 

“Common
Stock” shall have the meaning set forth in the recitals of this Agreement.

 

“Company”
shall have the meaning set forth in the preamble of this Agreement.

 

“Control”
or “Controls” shall have the meaning specified in Section 5(H).

 

“DTC”
shall have the meaning specified in Section 2(E).

 

“DWAC”
shall have the meaning specified in Section 2(E).

 

“Effective
Date” shall mean the date the SEC declares effective under the 1933 Act the Registration Statement covering the Securities.

 

“Equity
Line Transaction Documents” shall mean this Agreement and the Registration Rights Agreement.

 

“FAST”
shall have the meaning specified in Section 2(E).

 

“Indemnities”
shall have the meaning specified in Section 10.

 

“Indemnified
Liabilities” shall have the meaning specified in Section 10.

 

“Indemnitor”
shall have the meaning specified in Section 10.

 

“Investor”
shall have the meaning indicated in the preamble of this Agreement.

 

“Material
Adverse Effect” shall have the meaning specified in Section 4(A).

 

“Maximum
Common Stock Issuance” shall have the meaning specified in Section 2(F).

 

“Minimum
Acceptable Price” with respect to any Put Notice Date shall be the price defined by the Company in the applicable Put
Notice.

 

“Open
Market Adjustment Amount” shall have the meaning specified in Section 2(G).

 

“Open
Market Share Purchase” shall have the meaning specified in Section 2(G).

 

“Open
Period” shall mean the period beginning on and including the Trading Day immediately following the Effective Date and
ending on the earlier to occur of (i) the date which is thirty-six (36) months from the Effective Date; or (ii) termination of
the Agreement in accordance with Section 9, below.

 

“Pricing
Period” shall mean the five (5) consecutive Trading Days beginning on the Put Notice Date and ending on and including
the date that is four (4) Trading Days after such Put Notice Date.

 

“Principal
Market” shall mean the Nasdaq Capital Market, the NYSE Amex, the New York Stock Exchange, the Nasdaq Global Market,
the Nasdaq Global Select Market or the OTC Bulletin Board, whichever is the principal market on which the Common Stock is listed.

 

“Prospectus”
shall mean the prospectus, preliminary prospectus and supplemental prospectus used in connection with the Registration Statement.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	2 	 

    	 

    

 

“Purchase
Amount” shall mean the total amount being paid by the Investor on a particular Closing Date to purchase the Securities.

 

“Purchase
Price” shall mean ninety-four percent (94%) of the lowest daily VWAP (as defined herein) of the Common Stock during
the Pricing Period.

 

“Put”
shall have the meaning set forth in Section 2(B) hereof.

 

“Put
Amount” shall have the meaning set forth in Section 2(B) hereof.

 

“Put
Notice” shall mean a written notice in the form attached hereto as Exhibit C, sent to the Investor by the Company stating
the Put Amount in U.S. dollars the Company intends to sell to the Investor pursuant to the terms of the Agreement and stating
the current number of Shares issued and outstanding on such date.

 

“Put
Notice Date” shall mean the Trading Day, as set forth below, immediately following the day on which the Investor receives
a Put Notice, however a Put Notice shall be deemed delivered on (a) the Trading Day it is received by facsimile or email by the
Investor if such notice is received prior to noon Eastern Time, or (b) the immediately succeeding Trading Day if it is received
by facsimile or otherwise after noon Eastern Time on a Trading Day. No Put Notice may be deemed delivered on a day that is not
a Trading Day.

 

“Put
Restriction” shall mean the days during the Pricing Period. During this time, the Company shall not be entitled to deliver
another Put Notice.

 

“Put
Shares Due” shall have the meaning specified in Section 2(G).

 

“Registration
Rights Agreement” shall have the meaning set forth in the recitals of this Agreement.

 

“Registration
Statement” means the registration statement of the Company filed under the 1933 Act covering the resale by the Investor
of the Common Stock issuable hereunder.

 

“Related
Party” shall have the meaning specified in Section 5(H).

 

“Resolutions”
shall have the meaning specified in Section 7(E).

 

“SEC”
shall mean the U.S. Securities & Exchange Commission.

 

“SEC
Documents” shall have the meaning specified in Section 4(F).

 

“Securities”
shall mean the shares of Common Stock issued pursuant to the terms of the Agreement.

 

“Shares”
shall mean the shares of the Company’s Common Stock.

 

“Subsequent
Purchasers” shall have the meaning specified in Section 2(G).

 

“Subsidiaries”
shall have the meaning specified in Section 4(A).

 

“Trading
Day” shall mean any day on which the Principal Market for the Common Stock is open for trading, from the hours of 9:30
am until 4:00 pm Boston Time.

 

“VWAP”
shall mean the volume weighted average price during a Trading Day.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	3 	 

    	 

    

 

SECTION
2. PURCHASE AND SALE OF COMMON STOCK.

 

(A)
PURCHASE AND SALE OF COMMON STOCK. Subject to the terms and conditions set forth herein, the Company may issue and sell to the
Investor, and the Investor shall purchase from the Company, up to that number of Shares having an aggregate Purchase Price of
ten million dollars ($10,000,000).

 

(B)
DELIVERY OF PUT NOTICES. Subject to the terms and conditions of the Equity Line Transaction Documents, and from time to time during
the Open Period, the Company may, in its sole discretion, deliver a Put Notice to the Investor which states the dollar amount
(designated in U.S. Dollars) (the “Put Amount”) of Shares which the Company intends to sell to the Investor on a Closing
Date (the “Put”). The Put Amount shall be equal to up to either 1) two hundred percent (200%) of the average daily
volume (U.S. market only) of the Common Stock for the three (3) Trading Days prior to the applicable Put Notice Date, multiplied
by the average of the three (3) daily closing prices immediately preceding the Put Date or 2) an amount not to exceed one hundred
thousand dollars ($100,000). The Company shall not be entitled to submit a Put Notice until the Pricing Period for the prior Put
has been completed. The Common Stock identified in the Put Notice shall be purchased for a price equal to the Purchase Price.

 

(C)
COMPANY’S RIGHT TO SUSPEND. On each Put Notice submitted to the Investor by the Company, the Company shall have the option
to specify a Suspension Price for that Put. In the event the Common Stock falls below the Suspension Price, the Put shall be temporarily
suspended. The Put shall resume at such time as the Common Stock is above the Suspension Price, provided the dates for the Pricing
Period for that particular Put are still valid. In the event the Pricing Period has been complete, any shares above the Suspension
Price due to the Investor shall be sold to the Investor by the Company at the Suspension Price under the terms of this Agreement.
The Suspension Price for a Put may not be changed by the Company once submitted to the Investor.

 

(D)
CONDITIONS TO INVESTOR’S OBLIGATION TO PURCHASE SHARES. Notwithstanding anything to the contrary in this Agreement, the
Company shall not be entitled to deliver a Put Notice and the Investor shall not be obligated to purchase any Shares at a Closing
unless each of the following conditions are satisfied:

 

(1)
a Registration Statement shall have been declared effective and shall remain effective and available for the resale of all the
Registrable Securities (as defined in the Registration Rights Agreement) at all times until the Closing with respect to the subject
Put Notice;

 

(2)
at all times during the period beginning on the related Put Notice Date and ending on and including the related Closing Date,
the Common Stock shall have been listed on the Principal Market and shall not have been suspended from trading thereon for a period
of two (2) consecutive Trading Days during the Open Period and the Company shall not have been notified of any pending or threatened
proceeding or other action to suspend the trading of the Common Stock;

 

(3)
the Company has complied with its obligations and is otherwise not in breach of or in default under this Agreement, the Registration
Rights Agreement or any other agreement executed in connection herewith which has not been cured prior to delivery of the Put
Notice;

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	4 	 

    	 

    

 

(4)
no injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed
or abandoned, prohibiting the purchase or the issuance of the Securities; and

 

(5)
the issuance of the Securities pursuant to this Agreement will not violate any shareholder approval requirements of the Principal
Market.

 

If
any of the events described in clauses (1) through (5) above occurs during a Pricing Period, then the Investor shall have no obligation
to purchase the Common Stock subject to the applicable Put Notice.

 

(E)
MECHANICS OF PURCHASE OF SHARES BY INVESTOR. The closing of the purchase by the Investor of Shares (a “Closing”) shall
occur on the date which is no later than five (5) Trading Days following the applicable Put Notice Date (each a “Closing
Date”). On each Closing Date, (I) the Company shall deliver to the Investor pursuant to this Agreement, certificates representing
the Shares to be issued to the Investor on such date and registered in the name of the Investor; and (II) the Investor shall deliver
to the Company the Purchase Price to be paid for such Shares, based on the Put Amount set forth in Section 2(B). In lieu of delivering
physical certificates representing the Securities and provided that the Company’s transfer agent then is participating in
The Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, upon request
of the Investor, the Company shall use all commercially reasonable efforts to cause its transfer agent to electronically transmit
the Securities by crediting the account of the Investor’s prime broker (as specified by the Investor within a reasonable
period in advance of the Investor’s notice) with DTC through its Deposit Withdrawal Agent Commission (“DWAC”)
system.

 

The
Company understands that a delay in the issuance of Securities beyond the Closing Date could result in economic damage to the
Investor. After the Effective Date, as compensation to the Investor for such loss, the Company agrees to make payments to the
Investor for late issuance of Securities (delivery of Securities after the applicable Closing Date) in accordance with the following
schedule (where “No. of Days Late” is defined as the number of trading days beyond the Closing Date, with the Amounts
being cumulative.):

 

	LATE PAYMENT FOR EACH NO. OF DAYS LATE
	1	$100
	2	$200
	3	$300
	4	$400
	5	$500
	6	$600
	7	$700
	8	$800
	9	$900
	10	$1000
	Over 10	$1,000 + $200 for each Business Day late beyond 10 days

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	5 	 

    	 

    

 

The
Company shall make any payments incurred under this Section in immediately available funds upon demand by the Investor. Nothing
herein shall limit the Investor’s right to pursue actual damages for the Company’s failure to issue and deliver the
Securities to the Investor, except that such late payments shall offset any such actual damages incurred by the Investor, and
any Open Market Adjustment Amount, as set forth below.

 

(F)
OVERALL LIMIT ON COMMON STOCK ISSUABLE. Notwithstanding anything contained herein to the contrary, if during the Open Period the
Company becomes listed on an exchange that limits the number of shares of Common Stock that may be issued without shareholder
approval, then the number of Shares issuable by the Company and purchasable by the Investor, shall not exceed that number of the
shares of Common Stock that may be issuable without shareholder approval (the “Maximum Common Stock Issuance”). If
such issuance of shares of Common Stock could cause a delisting on the Principal Market, then the Maximum Common Stock Issuance
shall first be approved by the Company’s shareholders in accordance with applicable law and the By-laws and Articles of
Incorporation of the Company, as amended. The parties understand and agree that the Company’s failure to seek or obtain
such shareholder approval shall in no way adversely affect the validity and due authorization of the issuance and sale of Securities
or the Investor’s obligation in accordance with the terms and conditions hereof to purchase a number of Shares in the aggregate
up to the Maximum Common Stock Issuance limitation, and that such approval pertains only to the applicability of the Maximum Common
Stock Issuance limitation provided in this Section 2(H).

 

(G)
OPEN MARKET ADJUSTMENT. If, by the third (3rd) business day after a Closing Date, the Company fails to deliver any portion of
the Securities subject to a Put Notice to the Investor (the “Put Shares Due”) and the Investor purchases, in an open
market transaction or otherwise, shares of Common Stock necessary to make delivery by the Investor of shares in respect of sales
to subsequent purchasers, pursuant to transactions entered into before the Closing Date (“Subsequent Purchasers”),
which such shares of Common Stock would have been delivered to the Investor by the Company but for the Company’s failure
to so deliver (the “Open Market Share Purchase”), then the Company shall pay to the Investor, in addition to any other
amounts due to Investor pursuant to the Put, and not in lieu thereof, the Open Market Adjustment Amount (as defined below). The
“Open Market Adjustment Amount” is the amount equal to the excess, if any, of (x) the Investor’s total purchase
price (including brokerage commissions, if any) for the Open Market Share Purchase minus (y) the net proceeds (after brokerage
commissions, if any) received by the Investor from the sale of the Put Shares Due to such Subsequent Purchasers. The Company shall
pay the Open Market Adjustment Amount to the Investor in immediately available funds within five (5) business days of written
demand by the Investor. By way of illustration and not in limitation of the foregoing, if the Investor purchases shares of Common
Stock having a total purchase price (including brokerage commissions) of $11,000 to cover an Open Market Share Purchase with respect
to shares of Common Stock it sold to Subsequent Purchasers for net proceeds of $10,000, the Open Market Adjustment Amount which
the Company will be required to pay to the Investor will be $1,000.

 

(H)
LIMITATION ON AMOUNT OF OWNERSHIP. Notwithstanding anything to the contrary in this Agreement, in no event shall the Investor
be entitled to purchase that number of Shares, which when added to the sum of the number of shares of Common Stock beneficially
owned (as such term is defined under Section 13(d) and Rule 13d-3 of the 1934 Act), by the Investor, would exceed 4.99% of the
number of shares of Common Stock outstanding on the Closing Date, as determined in accordance with Rule 13d-1(j) of the 1934 Act.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	6 	 

    	 

    

 

SECTION
3. INVESTOR’S REPRESENTATIONS, WARRANTIES
AND COVENANTS. The Investor represents and warrants to the Company, and covenants, that:

 

(A)
SOPHISTICATED INVESTOR. The Investor has, by reason of its business and financial experience, such knowledge, sophistication and
experience in financial and business matters and in making investment decisions of this type that it is capable of (1) evaluating
the merits and risks of an investment in the Securities and making an informed investment decision; (2) protecting its own interest;
and (3) bearing the economic risk of such investment for an indefinite period of time.

 

(B)
AUTHORIZATION; ENFORCEMENT. The Investor has the requisite power and authority to enter into and perform this Agreement and the
Registration Rights Agreement. The execution and delivery of the Equity Line Transaction Documents by the Investor and the consummation
by it of the transactions contemplated hereby and thereby have been duly and validly authorized by the Investor’s general
partners and no further consent or authorization is required by its partners. This Agreement has been duly and validly authorized,
executed and delivered on behalf of the Investor and is a valid and binding agreement of the Investor enforceable against the
Investor in accordance with its terms, subject as to enforceability to general principles of equity and to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement
of applicable creditors’ rights and remedies.

 

(C)
SECTION 9 OF THE 1934 ACT. During the term of this Agreement, the Investor will comply with the provisions of Section 9 of the
1934 Act, and the rules promulgated thereunder, with respect to transactions involving the Common Stock. The Investor agrees not
to sell the Company’s stock short, either directly or indirectly through its affiliates, principals or advisors, the Company’s
common stock during the term of this Agreement.

 

(D)
ACCREDITED INVESTOR. Investor is an “Accredited Investor” as that term is defined in Rule 501(a) of Regulation D of
the 1933 Act.

 

(E)
NO CONFLICTS. The execution, delivery and performance of the Transaction Documents by the Investor and the consummation by the
Investor of the transactions contemplated hereby and thereby will not (1) result in a violation of the partnership agreement or
other organizational documents of the Investor, (2) conflict with, or constitute a material default (or an event which with notice
or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any material agreement, contract, indenture mortgage, indebtedness or instrument to which the Investor is
a party, or to the Investor’s knowledge result in a violation of any law, rule, regulation, order, judgment or decree (including
United States federal and state securities laws and regulations) applicable to the Investor or by which any property or asset
of the Investor is bound or affected.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	7 	 

    	 

    

 

(F)
NO VIOLATIONS. Except as disclosed in Schedule 3(f), the Investor is not in violation of any term of, or in default under, the
partnership agreement of other organizational documents of the Investor or any material contract, agreement, mortgage, indebtedness,
indenture, instrument, judgment, decree or order or any statute, rule or regulation applicable to the Investor, except for conflicts,
defaults, terminations, amendments, accelerations, cancellations and violations that would not, individually or in the aggregate,
constitute or reasonably be expected to constitute a material adverse effect on the Investor. The business of the Investor is
not being conducted, and shall not be conducted, in violation of any law, statute, ordinance, rule, order or regulation of any
governmental authority or agency, regulatory or self-regulatory agency, or court, except for violations the sanctions for which
either, individually or in the aggregate, would not have or reasonably be expected to have a material adverse effect on the Investor.
Except as specifically contemplated by this Agreement and as required under the 1933 Act or any securities laws of any states,
to the Investor’s knowledge, the Investor is not required to obtain any consent, authorization, permit or order of, or make
any filing or registration (except the filing of a registration statement as outlined in the Registration Rights Agreement) with,
any court, governmental authority or agency, regulatory or self-regulatory agency or other third party in order for it to execute,
deliver or perform any of its obligations under, or contemplated by, the Equity Line Transaction Documents in accordance with
the terms hereof or thereof except for those consents, authorizations, permits, orders or filings as have been obtained or effected
on or prior to the date hereof and are in full force and effect as of the date hereof. Except as disclosed in Schedule 3(f), the
Investor is unaware of any facts or circumstances which might give rise to any violation or default set forth in this Section
3(F).

 

(G)
OPPORTUNITY TO DISCUSS. The Investor has received all materials relating to the Company’s business, finance and operations
which it has requested. The Investor has had an opportunity to discuss the business, management and financial affairs of the Company
with the Company’s management.

 

(H)
INVESTMENT PURPOSES. The Investor is purchasing the Securities for its own account for investment purposes and not with a view
towards distribution and agrees to resell or otherwise dispose of the Securities solely in accordance with the registration provisions
of the 1933 Act (or pursuant to an exemption from such registration provisions).

 

(I)
NO REGISTRATION AS A DEALER. The Investor is not and will not be required to be registered as a “dealer” under the
1934 Act, either as a result of its execution and performance of its obligations under this Agreement or otherwise.

 

(J)
GOOD STANDING. The Investor is a Limited Partnership, duly organized, validly existing and in good standing in the state of Delaware.

 

(K)
TAX LIABILITIES. The Investor understands that it is liable for its own tax liabilities.

 

SECTION
4. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
Except as set forth in the Schedules attached hereto, or as disclosed in the Company’s SEC Documents, the Company represents
and warrants to the Investor that:

 

(A)
ORGANIZATION AND QUALIFICATION. The Company is a corporation duly organized and validly existing in good standing under the laws
of Colorado, USA and has the requisite corporate power and authorization to own its properties and to carry on its business as
now being conducted. Both the Company and the companies it owns or controls (“Subsidiaries”) are duly qualified to
do business and are in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted
by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would
not have a Material Adverse Effect. As used in this Agreement, “Material Adverse Effect” means any material adverse
effect on (1) the properties, assets, operations, results of operations, or financial condition of the Company and its Subsidiaries,
if any, taken as a whole, (2) the transactions contemplated hereby or by the agreements and instruments to be entered into in
connection herewith, or (3) the authority or ability of the Company to perform its obligations under the Equity Line Transaction
Documents other than as a result of (a) changes adversely affecting the United States economy (so long as the Company is not disproportionately
affected thereby), (b) changes adversely affecting the industry in which the Company operates (so long as the Company is not disproportionately
affected thereby), (c) the announcement or consummation of the transactions contemplated by this Agreement, and (d) changes in
the market price of the Common Stock.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	8 	 

    	 

    

 

(B)
AUTHORIZATION; ENFORCEMENT; COMPLIANCE WITH OTHER INSTRUMENTS.

 

(1)
The Company has the requisite corporate power and authority to enter into and perform the Equity Line Transaction Documents, and
to perform its obligations contemplated hereby and thereby.

 

(2)
The execution and delivery of the Equity Line Transaction Documents by the Company and the consummation by it of the transactions
contemplated hereby and thereby, including without limitation the reservation for issuance and the issuance of the Securities
pursuant to this Agreement, have been duly and validly authorized by the Company’s Board of Directors and no further consent
or authorization is required by the Company, its Board of Directors, or its shareholders.

 

(3)
The Equity Line Transaction Documents have been duly and validly executed and delivered by the Company.

 

(4)
The Equity Line Transaction Documents constitute the valid and binding obligations of the Company enforceable against the Company
in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies.

 

(C)
CAPITALIZATION. As of the date hereof, the authorized capital stock of the Company consists of 300,000,000 shares of Common Stock
with $0.001 par value per share, of as of March 3, 2017, 14,844,255 shares were issued and outstanding. Except as disclosed in
the Company’s publicly available filings with the SEC: (1) no shares of the Company’s capital stock are subject to
preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company; (2) there are
no outstanding debt securities; (3) there are no outstanding shares of capital stock, options, warrants, scrip, rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital
stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries
or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries; (4) there are no agreements
or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities
under the 1933 Act (except the Registration Rights Agreement); (5) there are no outstanding securities of the Company or any of
its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or
arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any
of its Subsidiaries; (6) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered
by the issuance of the Securities as described in this Agreement; (7) the Company does not have any stock appreciation rights
or “phantom stock” plans or agreements or any similar plan or agreement; and (8) there is no dispute as to the classification
of any shares of the Company’s capital stock.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	9 	 

    	 

    

 

The
Company has furnished to the Investor, or the Investor has had access through the SEC’s EDGAR website to, true and correct
copies of the Company’s Articles of Incorporation, as amended and in effect on the date hereof (the “Articles of Incorporation”),
and the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities
convertible into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.

 

(D)
ISSUANCE OF SHARES. The Company has initially reserved 20,000,000 Shares for issuance pursuant to this Agreement, which have been
duly authorized and reserved for issuance (subject to adjustment pursuant to the Company’s covenant set forth in Section
5(F) below) pursuant to this Agreement. Upon issuance in accordance with this Agreement, the Securities will be validly issued,
fully paid for and non-assessable and free from all taxes, liens and charges with respect to the issue thereof. In the event the
Company cannot register a sufficient number of Shares for issuance pursuant to this Agreement, the Company will use its best efforts
to authorize and reserve for issuance the number of Shares required for the Company to perform its obligations hereunder as soon
as reasonably practicable.

 

(E)
NO CONFLICTS. The execution, delivery and performance of the Equity Line Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby will not (I) result in a violation of the Articles of Incorporation,
any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the By-laws;
or (II) conflict with, or constitute a material default (or an event which with notice or lapse of time or both would become a
material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material
agreement, contract, indenture mortgage, indebtedness or instrument to which the Company or any of its Subsidiaries is a party,
or to the Company’s knowledge result in a violation of any law, rule, regulation, order, judgment or decree (including United
States federal and state securities laws and regulations and the rules and regulations of the Principal Market or principal securities
exchange or trading market on which the Common Stock is traded or listed) applicable to the Company or any of its Subsidiaries
or by which any property or asset of the Company or any of its Subsidiaries is bound or affected. Except as disclosed in Schedule
4(e), neither the Company nor its Subsidiaries is in violation of any term of, or in default under, the Articles of Incorporation,
any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the By-laws
or their organizational charter or by-laws, respectively, or any contract, agreement, mortgage, indebtedness, indenture, instrument,
judgment, decree or order or any statute, rule or regulation applicable to the Company or its Subsidiaries, except for possible
conflicts, defaults, terminations, amendments, accelerations, cancellations and violations that would not individually or in the
aggregate have or constitute a Material Adverse Effect. The business of the Company and its Subsidiaries is not being conducted,
and shall not be conducted, in violation of any law, statute, ordinance, rule, order or regulation of any governmental authority
or agency, regulatory or self-regulatory agency, or court, except for possible violations the sanctions for which either individually
or in the aggregate would not have a Material Adverse Effect. Except as specifically contemplated by this Agreement and as required
under the 1933 Act or any securities laws of any states, to the Company’s knowledge, the Company is not required to obtain
any consent, authorization, permit or order of, or make any filing or registration (except the filing of a registration statement
as outlined in the Registration Rights Agreement between the Parties) with, any court, governmental authority or agency, regulatory
or self-regulatory agency or other third party in order for it to execute, deliver or perform any of its obligations under, or
contemplated by, the Equity Line Transaction Documents in accordance with the terms hereof or thereof. All consents, authorizations,
permits, orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been
obtained or effected on or prior to the date hereof and are in full force and effect as of the date hereof. Except as disclosed
in Schedule 4(e), the Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any violation
or default of any of the foregoing. The Company is not, and will not be, in violation of the listing requirements of the Principal
Market as in effect on the date hereof and on each of the Closing Dates and is not aware of any facts which would reasonably lead
to delisting of the Common Stock by the Principal Market in the foreseeable future.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	10 	 

    	 

    

 

(F)
SEC DOCUMENTS; FINANCIAL STATEMENTS. As of the date hereof, the Company has filed all reports, schedules, forms, statements and
other documents required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents
incorporated by reference therein being hereinafter referred to as the “SEC Documents”). The Company has delivered
to the Investor or its representatives, or they have had access through the SEC’s EDGAR website to, true and complete copies
of the SEC Documents. As of their respective filing dates, the SEC Documents complied in all material respects with the requirements
of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the
SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC
Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations
of the SEC with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting
principles, and audited by a firm that is a member a member of the Public Companies Accounting Oversight Board (“PCAOB”)
consistently applied, during the periods involved (except (I) as may be otherwise indicated in such financial statements or the
notes thereto, or (II) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed
or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof
and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to
normal year-end audit adjustments). No other written information provided by or on behalf of the Company to the Investor which
is not included in the SEC Documents, including, without limitation, information referred to in Section 4(D) of this Agreement,
contains any untrue statement of a material fact or omits to state any material fact necessary to make the statements therein,
in the light of the circumstance under which they are or were made, not misleading. Neither the Company nor any of its Subsidiaries
or any of their officers, directors, employees or agents have provided the Investor with any material, nonpublic information which
was not publicly disclosed prior to the date hereof and any material, nonpublic information provided to the Investor by the Company
or its Subsidiaries or any of their officers, directors, employees or agents prior to any Closing Date shall be publicly disclosed
by the Company prior to such Closing Date.

 

(G)
ABSENCE OF CERTAIN CHANGES. Except as otherwise set forth in the SEC Documents, the Company does not intend to change the business
operations of the Company in any material way. The Company has not taken any steps, and does not currently expect to take any
steps, to seek protection pursuant to any bankruptcy law nor does the Company or its Subsidiaries have any knowledge or reason
to believe that its creditors intend to initiate involuntary bankruptcy proceedings.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	11 	 

    	 

    

 

(H)
ABSENCE OF LITIGATION AND/OR REGULATORY PROCEEDINGS. Except as set forth in the SEC Documents, there is no action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending
or, to the knowledge of the executive officers of Company or any of its Subsidiaries, threatened against or affecting the Company,
the Common Stock or any of the Company’s Subsidiaries or any of the Company’s or the Company’s Subsidiaries’
officers or directors in their capacities as such, in which an adverse decision could have a Material Adverse Effect.

 

(I)
ACKNOWLEDGMENT REGARDING INVESTOR’S PURCHASE OF SHARES. The Company acknowledges and agrees that the Investor is acting
solely in the capacity of an arm’s length purchaser with respect to the Equity Line Transaction Documents and the transactions
contemplated hereby and thereby. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Equity Line Transaction Documents and the transactions contemplated
hereby and thereby and any advice given by the Investor or any of its respective representatives or agents in connection with
the Equity Line Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Investor’s
purchase of the Securities, and is not being relied on by the Company. The Company further represents to the Investor that the
Company’s decision to enter into the Equity Line Transaction Documents has been based solely on the independent evaluation
by the Company and its representatives.

 

(J)
NO UNDISCLOSED EVENTS, LIABILITIES, DEVELOPMENTS OR CIRCUMSTANCES. Except as set forth in the SEC Documents, as of the date hereof,
no event, liability, development or circumstance has occurred or exists, or to the Company’s knowledge is contemplated to
occur, with respect to the Company or its Subsidiaries or their respective business, properties, assets, prospects, operations
or financial condition, that would be required to be disclosed by the Company under applicable securities laws on a registration
statement filed with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly
announced.

 

(K)
EMPLOYEE RELATIONS. Neither the Company nor any of its Subsidiaries is involved in any union labor dispute nor, to the knowledge
of the Company or any of its Subsidiaries, is any such dispute threatened. Neither the Company nor any of its Subsidiaries is
a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that relations with their employees
are good. No executive officer (as defined in Rule 501(f) of the 1933 Act) has notified the Company that such officer intends
to leave the Company’s employ or otherwise terminate such officer’s employment with the Company.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	12 	 

    	 

    

 

(L)
INTELLECTUAL PROPERTY RIGHTS. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted.
Except as set forth in the SEC Documents, none of the Company’s trademarks, trade names, service marks, service mark registrations,
service names, patents, patent rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or
other intellectual property rights necessary to conduct its business as now or as proposed to be conducted have expired or terminated,
or are expected to expire or terminate within two (2) years from the date of this Agreement. The Company and its Subsidiaries
do not have any knowledge of any infringement by the Company or its Subsidiaries of trademark, trade name rights, patents, patent
rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secret or other similar
rights of others, or of any such development of similar or identical trade secrets or technical information by others and, except
as set forth in the SEC Documents, there is no claim, action or proceeding being made or brought against, or to the Company’s
knowledge, being threatened against, the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights,
invention, copyright, license, service names, service marks, service mark registrations, trade secret or other infringement; and
the Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing. The
Company and its Subsidiaries have taken commercially reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties.

 

(M)
ENVIRONMENTAL LAWS. The Company and its Subsidiaries (I) are, to the knowledge of the Company and its Subsidiaries, in compliance
with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health
and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental Laws”);
(II) have, to the knowledge of the Company, received all permits, licenses or other approvals required of them under applicable
Environmental Laws to conduct their respective businesses; and (III) are in compliance, to the knowledge of the Company, with
all terms and conditions of any such permit, license or approval where, in each of the three (3) foregoing cases, the failure
to so comply would have, individually or in the aggregate, a Material Adverse Effect.

 

(N)
TITLE. The Company and its Subsidiaries have good and marketable title to all personal property owned by them which is material
to the business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects except
such as are described in the SEC Documents or such as do not materially affect the value of such property and do not interfere
with the use made and proposed to be made of such property by the Company or any of its Subsidiaries. Any real property and facilities
held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with
such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings
by the Company and its Subsidiaries.

 

(O)
INSURANCE. Each of the Company’s Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any of its Subsidiaries has been refused any insurance
coverage sought or applied for and neither the Company nor its Subsidiaries has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

(P)
REGULATORY PERMITS. The Company and its Subsidiaries have in full force and effect all certificates, approvals, authorizations
and permits from the appropriate federal, state, local or foreign regulatory authorities and comparable foreign regulatory agencies,
necessary to own, lease or operate their respective properties and assets and conduct their respective businesses, and neither
the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such
certificate, approval, authorization or permit, except for such certificates, approvals, authorizations or permits which if not
obtained, or such revocations or modifications which, would not have a Material Adverse Effect.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	13 	 

    	 

    

 

(Q)
INTERNAL ACCOUNTING CONTROLS. The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that (I) transactions are executed in accordance with management’s general or specific authorizations;
(II) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted
accounting principles by a firm with membership to the PCAOB and to maintain asset accountability; (III) reasonable controls to
safeguard assets are in place; and (IV) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.

 

(R)
NO MATERIALLY ADVERSE CONTRACTS, ETC. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or
other legal restriction, or any judgment, decree or order which in the judgment of the Company’s officers has or is expected
in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract or
agreement which in the judgment of the Company’s officers has or is expected to have a Material Adverse Effect.

 

(S)
TAX STATUS. The Company and each of its Subsidiaries has made or filed all United States federal and state income and all other
tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that
the Company and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid
and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside
on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns,
reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company know of no basis for any such claim.

 

(T)
CERTAIN TRANSACTIONS. Except as set forth in the SEC Documents filed at least ten (10) days prior to the date hereof and except
for arm’s length transactions pursuant to which the Company makes payments in the ordinary course of business upon terms
no less favorable than the Company could obtain from disinterested third parties and other than the grant of stock options disclosed
in the SEC Documents or stock options granted in the future as contemplated by current compensation agreements or plans disclosed
in the SEC Documents, none of the officers, directors, or employees of the Company is presently a party to any transaction with
the Company or any of its Subsidiaries (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property
to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company,
any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial interest
or is an officer, director, trustee or partner.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	14 	 

    	 

    

 

(U)
DILUTIVE EFFECT. The Company understands and acknowledges that the number of shares of Common Stock issuable upon purchases pursuant
to this Agreement will increase in certain circumstances including, but not necessarily limited to, the circumstance wherein the
trading price of the Common Stock declines during the period between the Effective Date and the end of the Open Period. The Company’s
executive officers and directors have studied and fully understand the nature of the transactions contemplated by this Agreement
and recognize that they have a potential dilutive effect on the shareholders of the Company. The Board of Directors of the Company
has concluded, in its good faith business judgment, and with full understanding of the implications, that such issuance is in
the best interests of the Company. The Company specifically acknowledges that, subject to such limitations as are expressly set
forth in the Equity Line Transaction Documents, its obligation to issue shares of Common Stock upon purchases pursuant to this
Agreement is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests
of other shareholders of the Company.

 

(V)
LOCK-UP. The Company shall cause its officers and directors to refrain from selling Common Stock during each Pricing Period.

 

(W)
NO GENERAL SOLICITATION. Neither the Company, nor any of its affiliates, nor any person acting on its behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale
of the Common Stock to be offered as set forth in this Agreement.

 

(X)
NO BROKERS, FINDERS OR FINANCIAL ADVISORY FEES OR COMMISSIONS. No brokers, finders or financial advisory fees or commissions will
be payable by the Company, its agents or Subsidiaries, with respect to the transactions contemplated by this Agreement, except
as otherwise disclosed in this Agreement.

 

SECTION
5. COVENANTS OF THE COMPANY

 

(A)
EFFORTS. The Company shall use all commercially reasonable efforts to timely satisfy each of the conditions set forth in Section
8 of this Agreement.

 

(B)
BLUE SKY. The Company shall, at its sole cost and expense, on or before each of the Closing Dates, take such action as the Company
shall reasonably determine is necessary to qualify the Securities for, or obtain exemption for the Securities for, sale to the
Investor at each of the Closings pursuant to this Agreement under applicable securities or “Blue Sky” laws of such
states of the United States, as reasonably specified by the Investor, and shall provide evidence of any such action so taken to
the Investor on or prior to the Closing Date.

 

(C)
REPORTING STATUS. Until one of the following occurs, the Company shall file all reports required to be filed with the SEC pursuant
to the 1934 Act, and the Company shall not terminate its status, or take an action or fail to take any action, which would terminate
its status as a reporting company under the 1934 Act: (1) this Agreement terminates pursuant to Section 9, or (2) the date on
which the Investor has sold all the Securities; provided that the Investor shall promptly notify the Company after the Investor
has sold all the Securities.

 

(D)
USE OF PROCEEDS. The Company will use the proceeds from the sale of the Securities (excluding amounts paid by the Company for
fees as set forth in the Equity Line Transaction Documents) for general corporate and working capital purposes and acquisitions
or assets, businesses or operations or for other purposes that the Board of Directors, in its good faith, deems to be in the best
interest of the Company.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	15 	 

    	 

    

 

(E)
FINANCIAL INFORMATION. During the Open Period, the Company agrees to make available to the Investor via the SEC’s EDGAR
website or other electronic means the following documents and information on the forms set forth: (1) within five (5) Trading
Days after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, any
Current Reports on Form 8-K and any Registration Statements or amendments filed pursuant to the 1933 Act; (2) copies of any notices
and other information made available or given to the shareholders of the Company generally, contemporaneously with the making
available or giving thereof to the shareholders; and (3) within two (2) calendar days of filing or delivery thereof, copies of
all documents filed with, and all correspondence sent to, the Principal Market, any securities exchange or market, or the Financial
Industry Regulatory Authority, unless such information is material nonpublic information.

 

(F)
RESERVATION OF SHARES. The Company shall initially reserve 20,000,000 Shares for the issuance of the Securities to the Investor
as required hereunder. In the event that the Company determines that it does not have a sufficient number of authorized shares
of Common Stock to reserve and keep available for issuance as described in this Section 5(F), the Company shall use all commercially
reasonable efforts to increase the number of authorized shares of Common Stock by seeking shareholder approval for the authorization
of such additional shares.

 

(G)
LISTING. The Company shall promptly secure and maintain the listing of all of the Registrable Securities (as defined in the Registration
Rights Agreement) on the Principal Market and each other national securities exchange and automated quotation system, if any,
upon which shares of Common Stock are then listed (subject to official notice of issuance) and shall maintain, such listing of
all Registrable Securities from time to time issuable under the terms of the Equity Line Transaction Documents. Neither the Company
nor any of its Subsidiaries shall take any action which would be reasonably expected to result in the delisting or suspension
of the Common Stock on the Principal Market (excluding suspensions of not more than one (1) trading day resulting from business
announcements by the Company). The Company shall promptly provide to the Investor copies of any notices it receives from the Principal
Market regarding the continued eligibility of the Common Stock for listing on such automated quotation system or securities exchange.
The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 5(G).

 

(H)
TRANSACTIONS WITH AFFILIATES. The Company shall not, and shall cause each of its Subsidiaries not to, enter into, amend, modify
or supplement, or permit any Subsidiary to enter into, amend, modify or supplement, any agreement, transaction, commitment or
arrangement with any of its or any Subsidiary’s officers, directors, persons who were officers or directors at any time
during the previous two (2) years, shareholders who beneficially own 5% or more of the Common Stock, or Affiliates or with any
individual related by blood, marriage or adoption to any such individual or with any entity in which any such entity or individual
owns a 5% or more beneficial interest (each a “Related Party”), except for (1) customary employment arrangements and
benefit programs on reasonable terms, (2) any agreement, transaction, commitment or arrangement on an arms-length basis on terms
no less favorable than terms which would have been obtainable from a disinterested third party other than such Related Party,(3)
any agreement, transaction, commitment or arrangement which is approved by a majority of the disinterested directors of the Company,
or (4) extensions or amendments of any existing employment agreement. For purposes hereof, any director who is also an officer
of the Company or any Subsidiary of the Company shall not be a disinterested director with respect to any such agreement, transaction,
commitment or arrangement. “Affiliate” for purposes hereof means, with respect to any person or entity, another person
or entity that, directly or indirectly, (1) has a 5% or more equity interest in that person or entity, (2) has 5% or more common
ownership with that person or entity, (3) controls that person or entity, or (4) is under common control with that person or entity.
“Control” or “Controls” for purposes hereof means that a person or entity has the power, directly or indirectly,
to conduct or govern the policies of another person or entity.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	16 	 

    	 

    

 

(I)
FILING OF FORM 8-K. On or before the date which is four (4) Trading Days after the date of execution of this Agreement, the Company
shall file a Current Report on Form 8-K with the SEC describing the terms of the transaction contemplated by the Equity Line Transaction
Documents in the form required by the 1934 Act, if such filing is required.

 

(J)
CORPORATE EXISTENCE. The Company shall use all commercially reasonable efforts to preserve and continue the corporate existence
of the Company.

 

(K)
NOTICE OF CERTAIN EVENTS AFFECTING REGISTRATION; SUSPENSION OF RIGHT TO MAKE A PUT. The Company shall promptly notify the Investor
upon the occurrence of any of the following events in respect of a Registration Statement or related prospectus in respect of
an offering of the Securities: (1) receipt of any request for additional information by the SEC or any other federal or state
governmental authority during the period of effectiveness of the Registration Statement for amendments or supplements to the Registration
Statement or related prospectus; (2) the issuance by the SEC or any other federal or state governmental authority of any stop
order suspending the effectiveness of any Registration Statement or the initiation of any proceedings for that purpose; (3) receipt
of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Securities
for sale in any jurisdiction or the initiation or notice of any proceeding for such purpose; (4) the happening of any event that
makes any statement made in such Registration Statement or related prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement,
related prospectus or documents so that, in the case of a Registration Statement, it will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not
misleading, and that in the case of the related prospectus, it will not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and (5) the Company’s reasonable determination that a post-effective amendment
to the Registration Statement would be appropriate, and the Company shall promptly make available to Investor any such supplement
or amendment to the related prospectus. The Company shall not deliver to the Investor any Put Notice during the continuation of
any of the foregoing events in this Section 5(K).

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	17 	 

    	 

    

 

(L)
REIMBURSEMENT. If (I) the Investor becomes involved in any capacity in any action, proceeding or investigation brought by any
shareholder of the Company, in connection with or as a result of the consummation of the transactions contemplated by the Equity
Line Transaction Documents, or if the Investor is impleaded in any such action, proceeding or investigation by any person (other
than as a result of a breach of the Investor’s representations and warranties set forth in this Agreement); or (II) the
Investor becomes involved in any capacity in any action, proceeding or investigation brought by the SEC against or involving the
Company (unless the Company is involved in the action, proceeding or investigation as a witness only) or in connection with or
as a result of the consummation of the transactions contemplated by the Equity Line Transaction Documents (other than as a result
of a breach of the Investor’s representations and warranties set forth in this Agreement), or if this Investor is impleaded
in any such action, proceeding or investigation by any person, then in any such case, the Company will reimburse the Investor
for its actual, reasonable legal and other expenses (including the cost of any investigation and preparation) incurred in connection
therewith, as such expenses are incurred. In addition, other than with respect to any matter in which the Investor is a named
party, the Company will pay to the Investor the charges, as reasonably determined by the Investor, for the time of any officers
or employees of the Investor devoted to appearing and preparing to appear as witnesses, assisting in preparation for hearings,
trials or pretrial matters, or otherwise with respect to inquiries, hearing, trials, and other proceedings relating to the subject
matter of this Agreement. The reimbursement obligations of the Company under this section shall be in addition to any liability
which the Company may otherwise have, shall extend upon the same terms and conditions to any affiliates of the Investor that are
actually named in such action, proceeding or investigation, and partners, directors, agents, employees, attorneys, accountants,
auditors and controlling persons (if any), as the case may be, of Investor and any such affiliate, and shall be binding upon and
inure to the benefit of any successors of the Company, the Investor and any such affiliate and any such person. However, in all
events, if the Investor is found to be guilty of violations of the federal or state securities laws (or pleads “no contest”
or other similar plea or settles an investigation or pleading without a specific finding of liability but is still subject to
civil or criminal liability), the Company will have no responsibility to pay any of the Investor’s fees and expenses regardless
of whether or not the Company is or is also found to have liability.

 

(M)
TRANSFER AGENT. Upon effectiveness of the Registration Statement, and for so long as the Registration Statement is effective,
the Company shall deliver instructions to its transfer agent to issue Shares to the Investor that are covered for resale by the
Registration Statement free of restrictive legends.

 

(N)
ACKNOWLEDGEMENT OF TERMS. The Company hereby represents and warrants to the Investor that: (1) it is voluntarily entering into
this Agreement of its own freewill, (2) it is not entering this Agreement under economic duress, (3) the terms of this Agreement
are reasonable and fair to the Company, and (4) the Company has had independent legal counsel of its own choosing review this
Agreement, advise the Company with respect to this Agreement, and represent the Company in connection with this Agreement.

 

SECTION
6. CONDITIONS OF THE COMPANY’S OBLIGATION
TO SELL. The obligation hereunder of the Company to issue and sell the Securities to the Investor is further subject to the satisfaction,
at or before each Closing Date, of each of the following conditions set forth below. These conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion.

 

(A)
The Investor shall have executed this Agreement and the Registration Rights Agreement and delivered the same to the Company.

 

(B)
The Investor shall have delivered to the Company the Purchase Price for the Securities being purchased by the Investor between
the end of the Pricing Period and the Closing Date via a Put Settlement Sheet (hereto attached as Exhibit D). Immediately after
receipt of confirmation of delivery of such Securities to the Investor, the Investor, by wire transfer of immediately available
funds pursuant to the wire instructions provided by the Company, will disburse the funds constituting the Purchase Amount.

 

(C)
The representations and warranties of the Investor shall be true and correct in all material respects as of the date when made
and as of the applicable Closing Date as though made at that time and the Investor shall have performed, satisfied and complied
in all material respects with the covenants, agreements and conditions required by the Equity Line Transaction Documents to be
performed, satisfied or complied with by the Investor on or before such Closing Date.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	18 	 

    	 

    

 

(D)
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

SECTION
7. FURTHER CONDITIONS OF THE INVESTOR’S
OBLIGATION TO PURCHASE. The obligation of the Investor hereunder to purchase Shares is subject to the satisfaction, on or before
each Closing Date, of each of the following conditions set forth below.

 

(A)
The Company shall have executed the Equity Line Transaction Documents and Commitment Shares and delivered the same to the Investor.

 

(B)
The Common Stock shall be authorized for quotation on the Principal Market and trading in the Common Stock shall not have been
suspended by the Principal Market or the SEC, at any time beginning on the date hereof and through and including the respective
Closing Date (excluding suspensions of not more than one (1) Trading Day resulting from business announcements by the Company,
provided that such suspensions occur prior to the Company’s delivery of the Put Notice related to such Closing).

 

(C)
The representations and warranties of the Company shall be true and correct in all material respects as of the date when made
and as of the applicable Closing Date as though made at that time and the Company shall have performed, satisfied and complied
in all material respects with the covenants, agreements and conditions required by the Equity Line Transaction Documents to be
performed, satisfied or complied with by the Company on or before such Closing Date. The Investor may request an update as of
such Closing Date regarding the representation contained in Section 4(C) above.

 

(D)
The Company shall have executed and delivered to the Investor the certificates representing, or have executed electronic book-entry
transfer of, the Securities (in such denominations as the Investor shall request) being purchased by the Investor at such Closing.

 

(E)
The Board of Directors of the Company shall have adopted resolutions consistent with Section 4(B)(2) above (the “Resolutions”)
and such Resolutions shall not have been amended or rescinded prior to such Closing Date.

 

(F)
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

(G)
The Registration Statement shall be effective on each Closing Date and no stop order suspending the effectiveness of the Registration
statement shall be in effect or to the Company’s knowledge shall be pending or threatened. Furthermore, on each Closing
Date (1) neither the Company nor the Investor shall have received notice that the SEC has issued or intends to issue a stop order
with respect to such Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of such Registration
Statement, either temporarily or permanently, or intends or has threatened to do so (unless the SEC’s concerns have been
addressed and Investor is reasonably satisfied that the SEC no longer is considering or intends to take such action), and (2)
no other suspension of the use or withdrawal of the effectiveness of such Registration Statement or related prospectus shall exist.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	19 	 

    	 

    

 

(H)
At the time of each Closing, the Registration Statement (including information or documents incorporated by reference therein)
and any amendments or supplements thereto shall not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading or which would require public disclosure
or an update supplement to the prospectus.

 

(I)
If applicable, the shareholders of the Company shall have approved the issuance of any Shares in excess of the Maximum Common
Stock Issuance in accordance with Section 2(H) or the Company shall have obtained appropriate approval pursuant to the requirements
of Colorado law and the Company’s Articles of Incorporation and By-laws.

 

(J)
The conditions to such Closing set forth in Section 2(E) shall have been satisfied on or before such Closing Date.

 

(K)
The Company shall have certified to the Investor the number of Shares of Common Stock outstanding when a Put Notice is given to
the Investor. The Company’s delivery of a Put Notice to the Investor constitutes the Company’s certification of the
reservation for issuance of the necessary number of shares of Common Stock subject to a Put Notice.

 

SECTION
8. TERMINATION. This Agreement shall terminate
upon any of the following events:

 

(A)
when the Investor has purchased an aggregate of ten million dollars $10,000,000 in the Common Stock of the Company pursuant to
this Agreement; or,

 

(B)
on the date which is thirty-six (36) months after the Effective Date; or,

 

(C)
upon written notice of the Company to the Investor. Any and all shares, or penalties, if any, due under this Agreement shall be
immediately payable and due upon termination of this Agreement.

 

SECTION
9. SUSPENSION. The Company’s right to cause
the Investor to purchase Shares pursuant to a Put Notice, and the Investor’s obligation to purchase Shares under this Agreement
shall be suspended upon any of the following events, and shall remain suspended until such event is rectified:

 

(A)
The trading of the Common Stock is suspended by the SEC, the Principal Market or FINRA for a period of two (2) consecutive Trading
Days during the Open Period; or,

 

(B)
The Common Stock ceases to be registered under the 1934 Act or listed or traded on the Principal Market. Immediately upon the
occurrence of one of the above-described events, the Company shall send written notice of such event to the Investor.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	20 	 

    	 

    

 

SECTION
10. INDEMNIFICATION. In consideration of the
parties’ mutual obligations set forth in the Transaction Documents, each of the parties (in such capacity, an “Indemnitor”)
shall defend, protect, indemnify and hold harmless the other and all of the other party’s shareholders, officers, directors,
employees, counsel, and direct or indirect investors and any of the foregoing person’s agents or other representatives (including,
without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages,
and reasonable expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which
indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified
Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (A) any material misrepresentation
or breach of any representation or warranty made by the Indemnitor in the Equity Line Transaction Documents or any other certificate,
instrument or document contemplated hereby or thereby; (B) any material breach of any covenant, agreement or obligation of the
Indemnitor contained in the Equity Line Transaction Documents or any other certificate, instrument or document contemplated hereby
or thereby; or (C) any cause of action, suit or claim brought or made against such Indemnitee by a third party and arising out
of or resulting from the execution, delivery, performance or enforcement of the Equity Line Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby, except insofar as (Y) any such misrepresentation, breach or
any untrue statement, alleged untrue statement, omission or alleged omission is made in reliance upon and in conformity with information
furnished to Indemnitor which is specifically intended for use in the preparation of any such Registration Statement, preliminary
prospectus, prospectus or amendments to the prospectus, (Z) any such Indemnified Liabilities resulted or arose from the breach
by the Indemnitee party hereto of any representation, warranty, covenant or agreement of such Indemnitee contained in the Equity
Line Transaction Documents or the negligence, recklessness, willful misconduct or bad faith of such Indemnitee. To the extent
that the foregoing undertaking by the Indemnitor may be unenforceable for any reason, the Indemnitor shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. The indemnity
provisions contained herein shall be in addition to any cause of action or similar rights Indemnitor may have, and any liabilities
the Indemnitor or the Indemnitees may be subject to.

 

SECTION
11. GOVERNING LAW; DISPUTES SUBMITTED TO ARBITRATION.
All disputes arising under this agreement shall be governed by and interpreted in accordance with the laws of the Commonwealth
of Massachusetts, without regard to principles of conflict of laws. The parties to this agreement will submit all disputes arising
under this agreement to arbitration in Boston, MA before a single arbitrator of the American Arbitration Association (“AAA”).
The arbitrator shall be selected by application of the rules of the AAA, or by mutual agreement of the parties, except that such
arbitrator shall be an attorney admitted to practice law in Commonwealth of Massachusetts. No party to this Agreement will challenge
the jurisdiction or venue provisions as provided in this section. No party to this agreement will challenge the jurisdiction or
venue provisions as provided in this section. Nothing contained herein shall prevent the party from obtaining an injunction.

 

SECTION
12. LEGAL EXPENSES; FEE SHARES AND MISCELLANEOUS
EXPENSES. Except as otherwise set forth in the Equity Line Transaction Documents, each party shall pay the fees and expenses of
its advisers, counsel, the accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. Any attorneys’ fees and expenses incurred
by either the Company or the Investor in connection with the preparation, negotiation, execution and delivery of any amendments
to this Agreement or relating to the enforcement of the rights of any party, after the occurrence of any breach of the terms of
this Agreement by another party or any default by another party in respect of the transactions contemplated hereunder, shall be
paid on demand by the party which breached the Agreement and/or defaulted, as the case may be. The Company shall pay all stamp
and other taxes and duties levied in connection with the issuance of any Securities. The Company agrees to pay $20,000 for the
preparation of the Equity Line Transaction Documents. As of the date of this Agreement $5,000 has been paid. The balance of $15,000
shall be payable per the promissory note dated February 23, 107 and signed between the Company and Investor. If the Company is
not DWAC eligible at the time of a Put Closing, there will be a $2,000 charge on each Closing Date to cover costs associated with,
but not limited to: deposit costs, legal review fees and wire fees. If the Company is DWAC eligible at the time of a Put Closing,
there will be a $500 charge on each Closing Date.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	21 	 

    	 

    

 

SECTION
13. COUNTERPARTS. This Agreement may be executed
in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature shall be
considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were
an original signature.

 

SECTION
14. HEADINGS; SINGULAR/PLURAL. The headings of
this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. Whenever
required by the context of this Agreement, the singular shall include the plural and masculine shall include the feminine.

 

SECTION
15. SEVERABILITY. If any provision of this Agreement
shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability
of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in
any other jurisdiction.

 

SECTION
16. ENTIRE AGREEMENT; AMENDMENTS. This Agreement
is the FINAL AGREEMENT between the Company and the Investor with respect to the terms and conditions set forth herein, and, the
terms of this Agreement may not be contradicted by evidence of prior, contemporaneous, or subsequent oral agreements of the Parties.
No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Investor, and
no provision hereof may be waived other than by an instrument in writing signed by the party against whom enforcement is sought.
The execution and delivery of the Equity Line Transaction Documents shall not alter the force and effect of any other agreements
between the Parties, and the obligations under those agreements.

 

SECTION
17. NOTICES. Any notices or other communications
required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered
(A) upon receipt, when delivered personally; (B) upon receipt, when sent by facsimile or email with the signed document attached
in PDF format (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending
party); or (C) one (1) day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses and facsimile numbers for such communications shall be:

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	22 	 

    	 

    

 

If
to the Company:

 

PHI
GROUP, INC.

5348
Vegas Drive

Las
Vegas, NV 89108

Telephone:
(702) 475-5430

 

If
to the Investor:

 

AZURE
CAPITAL

50
Commonwealth Avenue, Suite 2

Boston,
MA 02116

Telephone:
(617) 301-4701

 

Each
party shall provide five (5) days prior written notice to the other party of any change in address or facsimile number.

 

SECTION
18. NO ASSIGNMENT. This Agreement and any rights,
agreements or obligations hereunder may not be assigned, by operation of law, merger or otherwise, and any purported assignment
by a party without prior written consent of the other party will be null and void and not binding on such other party. Subject
to the preceding sentence, all of the terms, agreements, covenants, representations, warranties and conditions of this Agreement
are binding upon, and inure to the benefit of and are enforceable by, the parties and their respective successors and assigns.

 

SECTION
19. NO THIRD PARTY BENEFICIARIES. This Agreement
is intended for the benefit of the parties hereto and is not for the benefit of, nor may any provision hereof be enforced by,
any other person, except that the Company acknowledges that the rights of the Investor may be enforced by its general partner.

 

SECTION
20. SURVIVAL. The indemnification provisions
set forth in Section 11, shall survive each of the Closings and the termination of this Agreement.

 

SECTION
21. PUBLICITY. The Company and the Investor shall
consult with each other in issuing any press releases or otherwise making public statements with respect to the transactions contemplated
hereby and no party shall issue any such press release or otherwise make any such public statement without the prior consent of
the other party, which consent shall not be unreasonably withheld or delayed, except that no prior consent shall be required if
such disclosure is required by law, in which such case the disclosing party shall provide the other party with prior notice of
such public statement. The Investor acknowledges that this Agreement and all or part of the Equity Line Transaction Documents
may be deemed to be “material contracts” as that term is defined by Item 601(b)(10) of Regulation S-B, and that the
Company may therefore be required to file such documents as exhibits to reports or registration statements filed under the 1933
Act or the 1934 Act. The Investor further agrees that the status of such documents and materials as material contracts shall be
determined solely by the Company, in consultation with its counsel.

 

SECTION
22. FURTHER ASSURANCES. Each party shall do and
perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish
the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	23 	 

    	 

    

 

SECTION
23. NO STRICT CONSTRUCTION. The language used
in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party, as the parties mutually agree that each has had a full and fair opportunity to
review this Agreement and seek the advice of counsel on it.

 

SECTION
24. REMEDIES. The Investor shall have all rights
and remedies set forth in this Agreement and the Registration Rights Agreement and all rights and remedies which such holders
have been granted at any time under any other agreement or contract and all of the rights which the Investor has by law. Any person
having any rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting
a bond or other security), to recover damages by reason of any default or breach of any provision of this Agreement, including
the recovery of reasonable attorneys fees and costs, and to exercise all other rights granted by law.

 

SECTION
25. PAYMENT SET ASIDE. To the extent that the
Company makes a payment or payments to the Investor hereunder or under the Registration Rights Agreement or the Investor enforces
or exercises its rights hereunder or thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under
any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then
to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and
continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

SECTION
26. PRICING OF COMMON STOCK. For purposes of
this Agreement, the VWAP of the Common Stock shall be as reported on a direct feed service.

 

SECTION
27. NON-DISCLOSURE OF NON-PUBLIC INFORMATION.

 

(A)
The Company shall not disclose non-public information concerning the Company to the Investor, its advisors, or its representatives.

 

(B)
Nothing herein shall require the Company to disclose non-public information to the Investor or its advisors or representatives,
provided, however, that notwithstanding anything herein to the contrary, the Company will, as hereinabove provided, immediately
notify the advisors and representatives of the Investor and, if any, underwriters, of any event or the existence of any circumstance
(without any obligation to disclose the specific event or circumstance) of which it becomes aware, constituting non-public information
(whether or not requested of the Company specifically or generally during the course of due diligence by such persons or entities),
which, if not disclosed in the prospectus included in the Registration Statement would cause such prospectus to include a material
misstatement or to omit a material fact required to be stated therein in order to make the statements, therein, in light of the
circumstances in which they were made, not misleading. Nothing contained in this Section 29 shall be construed to mean that such
persons or entities other than the Investor (without the written consent of the Investor prior to disclosure of such information)
may not obtain non-public information in the course of conducting due diligence in accordance with the terms of this Agreement
and nothing herein shall prevent any such persons or entities from notifying the Company of their opinion that based on such due
diligence by such persons or entities, that the Registration Statement contains an untrue statement of material fact or omits
a material fact required to be stated in the Registration Statement or necessary to make the statements contained therein, in
light of the circumstances in which they were made, not misleading.

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	24 	 

    	 

    

 

SECTION
28. ACKNOWLEDGEMENTS OF THE PARTIES. Notwithstanding
anything in this Agreement to the contrary, the parties hereto hereby acknowledge and agree to the following: (A) the Investor
makes no representations or covenants that it will not engage in trading in the securities of the Company, other than the Investor
will not sell short any of the Company’s common stock at any time during a Pricing Period; (B) the Company shall, by 8:30
a.m. Boston Time on the fourth Trading Day following the date hereof, file a current report on Form 8-K disclosing the material
terms of the transactions contemplated hereby and in the other Equity Line Transaction Documents; (C) the Company has not and
shall not provide material non-public information to the Investor unless prior thereto the Investor shall have executed a written
agreement regarding the confidentiality and use of such information; and (D) the Company understands and confirms that the Investor
will be relying on the acknowledgements set forth in clauses (A) through (C) above if the Investor effects any transactions in
the securities of the Company.

 

[Signature
Page Follows]

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	25 	 

    	 

    

 

SIGNATURE
PAGE OF INVESTMENT AGREEMENT

 

Your
signature on this Signature Page evidences your agreement to be bound by the terms and conditions of the Investment Agreement
and the Registration Rights Agreement as of the date first written above.

 

The
undersigned signatory hereby certifies that he has read and understands the Investment Agreement, and the representations made
by the undersigned in this Investment Agreement are true and accurate, and agrees to be bound by its terms.

 

	 	AZURE CAPITAL
	 	 	 
	 	By:	/s/
    Douglas H. Leighton
	 	 	Douglas
    H. Leighton
	 	 	Chief
    Executive Officer
	 	 	 
	 	PHI GROUP, INC.
	 	 	 
	 	By:	/s/
    Henry D. Fahman
	 	 	Henry
    D. Fahman
	 	 	Chief
    Executive Officer

 

    	PHI GROUP INVESTMENT AGREEMENT MARCH 2017	26 	 

    	 

    

 

LIST
OF EXHIBITS

 

	EXHIBIT
    A	Registration
    Rights Agreement
	EXHIBIT B	Opinion of Company’s
    Counsel
	EXHIBIT C	Put Notice
	EXHIBIT D	Put Settlement Sheet

 

    	 

    	 

    

 

EXHIBIT
A

 

REGISTRATION
RIGHTS AGREEMENT

 

(Attached)

 

    	 	A-1	 

    	 

    

 

EXHIBIT
B

 

OPINION
OF COMPANY’S COUNSEL

 

(Attached)

 

    	 	B-1 	 

    	 

    

 

EXHIBIT
C

 

FORM
OF PUT NOTICE

 

Date:
____________

RE:
Put Notice Number ____________

Dear
Mr. Leighton:

 

This
is to inform you that as of today, PHI GROUP, INC. a Nevada corporation (the “Company”), hereby elects
to exercise its right pursuant to the Investment Agreement entered into with Azure Capital (“Azure”)
to require Azure to purchase shares of its common stock. The Company hereby certifies that:

 

1.
The undersigned is the duly elected ______________ of the Company.

 

2.
There are no fundamental changes to the information set forth in the Registration Statement which would require the Company to
file a post effective amendment to the Registration Statement.

 

3.
The Company has performed in all material respects all covenants and agreements to be performed by the Company and has complied
in all material respects with all obligations and conditions contained in this Agreement on or prior to the Put Notice Date, and
shall continue to perform in all material respects all covenants and agreements to be performed by the Company through the applicable
Put Date. All conditions to the delivery of this Put Notice are satisfied as of the date hereof.

 

4.
The undersigned hereby represents, warrants and covenants that it has made all filings (“SEC Filings”) required
to be made by it pursuant to applicable securities laws (including, without limitation, all filings required under the Securities
Exchange Act of 1934, which include Forms 10-Q, 10-K, 8-K, etc.). All SEC Filings and other public disclosures made by the Company,
including, without limitation, all press releases, analysts meetings and calls, etc. (collectively, the “Public Disclosures”),
have been reviewed and approved for release by the Company’s attorneys and, if containing financial information, the Company’s
independent certified public accountants. None of the Company’s Public Disclosures contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading.

 

5.
The amount of this put is up to____________ shares.

 

6.
The Pricing Period runs from ____________ until ____________.

 

7.
The Suspension Price is $ ____________

 

8.
The current number of shares issued and outstanding as of the Company are: ____________

 

9.
The number of shares currently available for resale pursuant to the Registration Statement on Form S-1 for the Equity Line are:
____________

 

	 	 	[Company
    Name]
	 	By:	 
	 	Name: 	 
	 	Title:	 

 

    	 

    	 

    

 

EXHIBIT
D

 

FORM
OF PUT SETTLEMENT SHEET

 

Date:
____________

 

RE:
PHI GROUP, INC.

 

Dear
: ____________

 

Pursuant
to the Put given by PHI GROUP, INC. to Azure Capital on ____________ 20__, we are now submitting the amount of common shares for
you to issue to Azure.

 

Please
deliver __________ shares to Azure Capital immediately and send via DWAC to the following account:

 

XXXXXX

 

Once
these shares are received by us, we will have the funds wired to the Company.

 

Regards,

 

Douglas
H. Leighton

 

    	 

    	 

    

 

	DATE	 	PRICE
	Date of Day 1	 	VWAP of Day 1
	Date of Day 2	 	VWAP of Day 2
	Date of Day 3	 	VWAP of Day 3
	Date of Day 4	 	VWAP of Day 4
	Date of Day 5	 	VWAP of Day 5

 

	LOWEST
    VWAP IN PRICING PERIOD	 
	 	 
	PUT AMOUNT 	 
	 	 
	PURCHASE PRICE (NINETY-FOUR
    PERCENT (94%))	 
	 	 
	AMOUNT OF SHARES
    DUE	 

 

The
undersigned has completed this Put as of this ___th day of _________, 20__.

 

	 	PHI GROUP, INC.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]